对儿科血液学疾病发育起源的机制性见解
Giuseppina Camiolo1, Christopher G Mullen1, Katrin Ottersbach1
1Centre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, United Kingdom.
Experimental hematology
|July 26, 2024
概括
胎儿血液干细胞具有独特的特性,可以导致儿童的侵袭性白血病. 了解这些发育性疾病是开发向治疗的关键.
科学领域:
- 血液学 血液学 血液学
- 发展生物学 发展生物学
- 在瘤学瘤学.
背景情况:
- 胚胎/胎儿造血干细胞 (HSC) 与成人造血干细胞相比,具有不同的特性,包括更高的自我更新和增殖率.
- 这些胎儿的特性虽然对发育至关重要,但可以促进具有产前起源的侵袭性婴儿和儿科白血病的发病.
- 目前针对成人白血病的治疗方法通常对这些发育性血液性恶性瘤无效.
研究的目的:
- 审查胎儿HSC与血液恶性瘤相关的独特特性.
- 详细介绍胎儿细胞表型的分子驱动因素及其在疾病发病过程中的作用.
- 描述产前起源的婴儿/儿科白血病的起源,表型和分子驱动因素.
主要方法:
- 文献综述侧重于胎儿HSC特性和儿科白血病.
- 对产前发作的血液性恶性瘤的分子驱动因素和细胞起源的分析.
- 检查这些疾病建模的最新进展,以确定治疗漏洞.
主要成果:
- 胎儿HSC表现出独特的特征,包括改变的全球蛋白基因表达和血统偏差.
- 胎儿细胞中的特定分子驱动因素有助于婴儿/儿科白血病的侵袭性疾病表型.
- 忠实的疾病模型揭示了潜在的治疗目标和途径.
结论:
- 产前发病的婴儿/儿科白血病是发育性疾病,需要专门的理解.
- 针对独特的胎儿细胞特性及其分子驱动因素提供了有希望的治疗策略.
- 对这些发育方面的进一步研究对于改善治疗结果至关重要.
相关概念视频
01:21Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
01:20Overview of Hematopoiesis
3.9K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.9K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:34Production of Formed Elements
1.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.4K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K